You are on page 1of 4

PUBLICATIONS

1. Khan MKA, Akhtar S and Arif JM. Development of in silico protocols to predict
structural insights into the metabolic activation pathways of xenobiotics. Interdiscip Sci
(2017) Accepted [INSC-D-15-00162R3] (IF=0.853).
2. Ahmad SS, Akhtar S, Rizvi SMD, Kamal MA, Sayeed U, Khan MKA, Siddiqui MH,
Arif JM. Screening and Elucidation of Selected Natural Compounds for Anti-Alzheimer's
Potential Targeting BACE-1 Enzyme: A Case Computational Study. Curr Comput Aided
Drug Des (2017) doi: 10.2174/1573409913666170414123825. [Epub ahead of print]
(IF=1.155).
3. Khan MKA, Akhtar S and Arif JM. Structural Insight into the Mechanism of
Dibenzo[a,l]pyrene and Benzo[a]pyrene-Mediated Cell Proliferation using Molecular
Docking Simulations. Interdiscip Sci (2017) doi:10.1007/s12539-017-0226-7[Epub
ahead of print] (IF=0.853).
4. Shakeel E, Arora D, Jamal QM, Akhtar S, Khan MK, Kamal MA, Siddiqui MH, Lohani
M, Arif JM. Marine drugs: A hidden wealth and a new epoch for cancer management.
Curr Drug Metab. 2017 Feb 20. [Epub ahead of print] (IF=2.847)
5. Sarkar A, Fatima I, Jamal QM, Sayeed U, Khan MK, Akhtar S, Kamal MA, Farooqui
A, Siddiqui MH. Nanoparticles as a Carrier System for Drug Delivery Across Blood
Brain Barrier. Curr Drug Metab. 2017 Jan 13. [Epub ahead of print] (IF=2.847)
6. Ahmad K, Khan MK, Baig MH, Lohani M, Kamal MA, Gupta GK. Role of Azoles in
cancer prevention and treatment: present and future perspectives. ANTI-CANCER
AGENT ME (2016) Dec 21.[Epub ahead of print] (IF=2.722)
7. Rehman A, Akhtar S, Siddiqui MH, Sayeed U, Ahmad SS, Arif JM, Khan MK.
Identification of potential leads against 4-hydroxytetrahydrodipicolinate synthase from
Mycobacterium tuberculosis. Bioinformation (2016) Dec 2, 12(11): 400-406.
8. Sarkar S, Osama K, Jamal QM, Kamal MA, Sayeed U, Khan MK, Siddiqui MH, Akhtar
S. Advances and Implications in Nanotechnology for Lung Cancer Management. Curr
Drug Metab (2016) Nov 14 [Epub ahead of print] (IF=2.847).
9. Sharma N, Akhtar S, Jamal QM, Kamal MA, Khan MK, Siddiqui MH, Sayeed U.
Elucidation of antiangiogenic potential of Vitexin obtained from Cucumis sativus
targeting Hsp90 protein: A novel multipathway targeted approach to restrain angiogenic
phenomenon. Med Chem (2016) Nov 11 [Epub ahead of print] (IF=1.458).
10. Ahmad S, Akhtar S, Sajid Jamal QM, Danish Rizvi SM, Kamal MA, Khan
MK, Siddiqui MH. Multiple targets for management of Alzheimer's disease: A review.
CNS Neurol Disord Drug Targets (2016) Oct 3 [Epub ahead of print] (IF=2.188).
11. Akhtar S, Khan MK, Arif JM. Evaluation and Elucidation Studies of Natural Aglycones
for Anticancer Potential Using Apoptosis-related Markers: An In silico Study. Interdiscip
Sci (2016) Oct 5 [Epub ahead of print] (IF=0.853).
12. N Bano, IF Rizvi, MH Siddiqui, MKA Khan, S Akhtar. Production of Bioactive
Secondary Metabolites from Endophytic fungi (2016). International Research Journal of
Engineering and Technology 3 (06), 08.
13. Alam A, Rizvi IF, Sayeed U, Khan MKA, Akhtar S, Farooqui A, and Siddiqui MHS.
Application of nanotechnology in agriculture and food science (2016), World Journal of
Pharmaceutical Sciences 4 (7), 45-54 (Review article).
14. Trivedi P, Hasan A, Akhtar S, Siddiqui MH, Sayeed U and Khan MKA. Role of
microbes in degradation of synthetic plastics and manufacture of bioplastics (2016), J
Chem Pharm Res, 8 (3): 211-216 (Review article).
15. Shahi N, Hasan A, Akhtar S, Siddiqui MH, Sayeed U and Khan MKA. Xylanase: A
promising enzyme (2016), J Chem Pharm Res, 8 (3): 334-339 (Review article).
16. Khan. M.K.A., Siddiqui. M.H., Farooqui. A., Mishra. M., Sayeed. U. and Akhtar. S.
Computer-aided vaccine designing by adopting the epitopes of envelope protein isolates
from Japanese encephalitis virus Indian strain P20778 (2015), Wulfenia 22 (12): 42-57
(IF=2.00).
17. Baig M.H, A Khurshid, H. Qambar, Khan M K A, S. Naidu, Kamal M.H and Choi I.
Interaction of glucagon G-protein coupled receptor with known natural anti-diabetic
compounds: Multi-scoring in silico approach (2015), Evid Based Complement Alternat
Med 2015:01-06, Article ID 497253 (IF=1.931).
18. Mohd H Baig. M.H., D Raja Sudhakar; Ponnusamy Kalaiarasan; Naidu Subbarao;
Gulshan Wadhawa; Mohtashim Lohani; M K A Khan and Asad U Khan. Insight into the
effect of inhibitor resistant S130G mutant on physico-chemical properties of SHV type
beta-lactamase: A Molecular Dynamics study. (2014), PLOS ONE 9(12): e112456.
doi:10.1371/journal.pone (IF=3.057).
19. Khan. M.K.A., Ansari. I.A., Khan. M.S. Dietary Phytochemicals as Potent
Chemotherapeutic agents against Breast Cancer: Inhibition of NF-B Pathway via
Molecular Interactions in Rel Homology Domain of its Precursor Protein p105. (2013)
Pharmacogn Mag 9: 51-57 (IF=0.831).
20. Gupta C.L., Khan M.K.A., khan M.F and Tiwari A.K. Homology modeling of
LmxMPK4 of Leishmania mexicana and virtual screening of potent inhibitors against It
(2013), Interdiscip Sci 5 (2): 136-44 (IF=0.853).
21. Khan. M.S., Khan. M.K.A., Siddiqui. M.H. and Arif. J.M. An in vivo and in silico
approach to elucidate the Tocotrienol-mediated fortification against infection and
inflammation induced alterations in antioxidant defense system (2011), Eur Rev Med
Pharmacol Sci 15(8): 916-930 (IF=1.575).
22. Khan. M.K.A., Siddiqui. M.H., Akhtar. S., Ahmad. K., Baig. M.H and Osama K.
Screening of plant-derived natural compounds as potent chemotherapeutic agents against
breast cancer: An in silico approach (2015), J Chem Pharm Res 7 (1): 519-526.
23. Sinha.M., Khan M.K.A., Siddiqui. M. H., Sayeed. U., Wadhwa. G., and Akhtar S.
Pharmacogenomics: A Step Ahead In Modern Day Drug Discovery (2014), International
Journal of Advanced Engineering Science & Research 1 (8): 1-14 (Review article).
24. Sayeed. U., Wadhwa. G., Khan. M.K.A., Q.M.S. Jamal., S. Akhtar and M.S. Khan. An
Immuno-informatics driven Epitope study from the molecular interaction of JEV non-
structural (NS) proteins with Ribophorin (RPN) (2014), Bioinformation 10 (8): 496-501.
25. Al-Khodairy F.M., Khan. M.K.A., Kunhi M., Pulicat. M.S and Arif J.M. Erysolin
induces apoptosis in human breast cancer cell lines: Evidences from in vitro and in silico
studies (2013), Am J Bioinform Res 3 (3): 62-71.
26. Khan. M.K.A., Akhtar. S. and Arif. J.M. Homology Modeling of CYP1A1, CYP1B1
and its Subsequent Molecular Docking Studies with Resveratrol and its Analogues using
AutoDock Tools 4.0 (2011), Biochem. Cell. Arch. 11(1): 49-55.
27. Khan. M.K.A., Akhtar. S., Siddiqui. M.H., Al-Sagair. O. and Arif. J.M. In silico
Elucidation and Validation of Metabolic activation/detoxification process of dibenzo [a,l]
pyrene and its metabolites using AutoDock Tools 4.0. (2011), J Chem Pharm Res
3(1):756-763.
28. Khan. M.K.A., Arif. J.M. and Jamal F., Efficacy of Natural Inhibitors against PKC
(2011), Recent Research in Science and Technology. 3(4): 90-93.
29. Khan. M.K.A., Khan. M.S., Siddiqui. S.A., Siddiqui. M.S., Srinivasan. K.V., Siddiqui.
M.H. and Arif. J.M. An in silico Elucidation of Inhibition of Cathepsin D by 2, 4, 5-
triaryl Imidazole (2011), Biomirror 2(5): 1-8.
30. Gupta C.L., Singh S. and Khan M.K.A., Molecular docking studies of antimalarial drug
and its analogues against falcipain-2 protein (2011), Online International Journal of
Biosolution.1 (1):14-22.
31. Shahid S.M.A., Khan. M.K.A., Baig.M.H and Lohani. M. An in silico Study of Plant-
Derived Natural Compounds as Chemopreventive Agents against Matrix
Metalloproteinase-9 Using GOLD (2011), International Journal of Soft Computing and
Bioinformatics. 2 (2): 43-53.